Total Non-Current Liabilities

kr 134.58B

Quarterly · Period ending: Jun 30, 2026 · DKK

Latest reportedkr 133.19B DKKperiod endingDec 31, 2025

NVO FY Total Non-Current Liabilities · DKK (kr 843.51M → kr 133.19B)

Annual total non-current liabilities

High-resolution chart · PNG

NVO total non-current liabilities history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Total Non-Current Liabilities — Annual fiscal periods (DKK)
Period ending	Total Non-Current Liabilities (DKK)
Dec 31, 2025	133,194,000,000
Dec 31, 2024	104,781,000,000
Dec 31, 2023	38,270,000,000
Dec 31, 2022	36,831,000,000
Dec 31, 2021	24,246,000,000
Dec 31, 2020	11,324,000,000
Dec 31, 2019	9,036,000,000
Dec 31, 2018	4,766,000,000
Dec 31, 2017	5,484,000,000
Dec 31, 2016	4,834,000,000
Dec 31, 2015	3,957,000,000
Dec 31, 2014	3,079,000,000
Dec 31, 2013	3,543,000,000
Dec 31, 2012	3,399,000,000
Dec 31, 2011	6,471,000,000
Dec 31, 2010	5,961,000,000
Dec 31, 2009	5,593,000,000
Dec 31, 2008	4,680,550,000
Dec 31, 2007	4,914,554,000
Dec 31, 2006	4,407,468,000
Dec 31, 2005	3,738,260,140
Dec 31, 2004	3,676,832,700
Dec 31, 2003	2,548,373,700
Dec 31, 2002	2,597,512,230
Dec 31, 2001	2,756,823,300
Dec 31, 2000	2,438,444,800
Dec 31, 1999	5,847,870,910
Dec 31, 1998	3,818,864,392
Dec 31, 1997	2,197,208,718
Dec 31, 1996	1,349,813,146
Dec 31, 1995	1,787,849,200
Dec 31, 1994	3,417,465,800
Dec 31, 1993	3,594,555,000
Dec 31, 1992	2,796,280,500
Dec 31, 1991	1,914,199,950
Dec 31, 1990	1,303,065,600
Dec 31, 1989	1,754,291,250
Dec 31, 1988	972,671,000
Dec 31, 1987	983,365,450
Dec 31, 1986	1,879,680,000
Dec 31, 1985	843,512,400